Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 1,202.10%49.01M | ---- | 224.97%3.76M | ---- | -105.66%-3.01M | ---- | -72.17%53.24M | ---- | 1.87%191.29M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 23.29%-3.84M | ---- | 61.37%-5M | ---- | ---12.95M | ---- | ---- | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | 24.19%-376K | ---- | 5.52%-496K | ---- | 27.98%-525K |
| Impairment and provisions: | ---- | 1,082.08%20.25M | ---- | -89.89%1.71M | ---- | -63.15%16.95M | ---- | -19.35%45.99M | ---- | 70.26%57.02M |
| -Impairment of trade receivables (reversal) | ---- | 1,082.08%20.25M | ---- | -89.89%1.71M | ---- | -62.33%16.95M | ---- | -21.10%44.99M | ---- | 75.67%57.02M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1M | ---- | ---- |
| Revaluation surplus: | ---- | 155.96%4.14M | ---- | -127.46%-7.4M | ---- | 173.45%26.95M | ---- | ---36.69M | ---- | ---- |
| -Other fair value changes | ---- | 155.96%4.14M | ---- | -127.46%-7.4M | ---- | 173.45%26.95M | ---- | ---36.69M | ---- | ---- |
| Asset sale loss (gain): | ---- | -1,519.29%-1.99M | ---- | --140K | ---- | ---- | ---- | ---- | ---- | ---1.69M |
| -Loss (gain) from sale of subsidiary company | ---- | ---1.99M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.69M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | --140K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -6.59%11.37M | ---- | 5.13%12.18M | ---- | -24.50%11.58M | ---- | -7.28%15.34M | ---- | 1.78%16.55M |
| -Depreciation | ---- | -9.67%8.05M | ---- | 2.07%8.91M | ---- | -28.85%8.73M | ---- | -11.79%12.27M | ---- | -2.06%13.91M |
| -Amortization of intangible assets | ---- | 58.84%521K | ---- | 3,544.44%328K | ---- | -96.84%9K | ---- | -30.83%285K | ---- | 167.53%412K |
| Special items | ---- | -3.59%1.18M | ---- | -66.86%1.23M | ---- | 198.07%3.7M | ---- | -11,690.63%-3.77M | ---- | 99.48%-32K |
| Operating profit before the change of operating capital | ---- | 1,111.00%80.13M | ---- | -84.55%6.62M | ---- | -41.81%42.84M | ---- | -71.97%73.61M | ---- | 13.70%262.61M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -170.01%-13.76M | ---- | 132.28%19.65M | ---- | -134.19%-60.87M | ---- | 362.99%178.05M | ---- | 9.78%-67.7M |
| Accounts payable increase (decrease) | ---- | -432.20%-41.96M | ---- | -46.74%12.63M | ---- | 128.92%23.71M | ---- | -310.25%-82.01M | ---- | 196.02%39M |
| Special items for working capital changes | ---- | 96.47%-1.29M | ---- | -748.14%-36.65M | ---- | 213.40%5.65M | ---- | -302.35%-4.99M | ---- | 161.83%2.46M |
| Cash from business operations | 169.08%30.96M | 928.32%23.13M | 32.39%11.51M | -80.15%2.25M | 13.74%8.69M | -93.12%11.33M | -91.86%7.64M | -30.33%164.67M | 17.49%93.82M | 43.16%236.37M |
| Other taxs | -6,129.73%-2.31M | 85.99%-2.63M | 99.80%-37K | -280.37%-18.77M | -280.98%-18.77M | 129.63%10.41M | 143.64%10.37M | -16.61%-35.12M | -53.27%-23.76M | 29.27%-30.12M |
| Net cash from operations | 149.85%28.66M | 224.09%20.5M | 213.84%11.47M | -175.99%-16.52M | -155.94%-10.08M | -83.22%21.74M | -74.29%18.01M | -37.19%129.55M | 8.87%70.06M | 68.33%206.26M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -41.30%1.25M | -42.75%3.93M | -53.14%2.13M | -23.07%6.86M | 1.29%4.54M | 42.66%8.92M | 6.16%4.48M | -17.79%6.25M | 28.39%4.22M | 6.16%7.61M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | -24.19%376K | ---- | -5.52%496K | ---- | -27.98%525K |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | 242.30%90.74M | -22.61%90.74M | 123.02%26.51M | 5,483.29%117.25M | -336.69%-115.15M |
| Sale of fixed assets | -70.33%62K | -9.37%716K | 80.17%209K | 233.33%790K | -30.54%116K | -5.95%237K | 45.22%167K | -88.67%252K | -41.33%115K | 308.26%2.23M |
| Purchase of fixed assets | -111.49%-1.47M | 36.47%-1.87M | 31.76%-696K | 6.89%-2.95M | 42.05%-1.02M | 11.54%-3.17M | 31.06%-1.76M | 92.29%-3.58M | 93.84%-2.55M | -548.34%-46.41M |
| Purchase of intangible assets | ---10K | -130.92%-1.4M | ---- | -1,166.67%-608K | ---- | -500.00%-48K | ---- | 42.86%-8K | ---- | 98.10%-14K |
| Sale of subsidiaries | ---- | --1.37M | --1.37M | ---- | ---- | ---- | ---- | ---- | ---- | --445K |
| Recovery of cash from investments | ---- | --18.27M | --15.25M | ---- | ---- | ---- | ---- | --31.92M | ---- | ---- |
| Net cash from investment operations | -100.94%-172K | 412.89%21M | 402.67%18.26M | -95.78%4.1M | -96.12%3.63M | 56.93%97.06M | -21.34%93.63M | 141.02%61.85M | 431.63%119.03M | -406.49%-150.77M |
| Net cash before financing | -4.20%28.48M | 434.06%41.5M | 561.52%29.73M | -110.46%-12.42M | -105.77%-6.44M | -37.93%118.8M | -40.96%111.64M | 244.94%191.4M | 564.41%189.09M | -67.69%55.49M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | -7.66%-51.1M | 58.09%-47.46M | 58.09%-47.46M | -0.06%-113.23M | -0.06%-113.23M | 24.24%-113.16M | 24.24%-113.16M | -22.27%-149.37M | -22.27%-149.37M | 20.22%-122.16M |
| Other items of the financing business | 51.44%-321K | -1,580.46%-1.46M | ---661K | ---87K | ---- | ---- | ---- | ---7.74M | ---7.87M | ---- |
| Net cash from financing operations | -6.82%-51.77M | 56.55%-49.61M | 57.38%-48.46M | -0.21%-114.17M | -0.21%-113.71M | 27.82%-113.94M | 27.98%-113.47M | -28.56%-157.85M | -28.72%-157.55M | 20.03%-122.78M |
| Effect of rate | 81.61%-174K | 85.69%-225K | 28.77%-946K | -138.20%-1.57M | -143.92%-1.33M | 526.33%4.12M | 143.48%3.02M | 135.73%657K | 347.41%1.24M | -323.73%-1.84M |
| Net Cash | -24.31%-23.28M | 93.60%-8.11M | 84.41%-18.73M | -2,704.81%-126.59M | -6,462.04%-120.15M | -85.51%4.86M | -105.80%-1.83M | 149.85%33.55M | 133.58%31.54M | -470.06%-67.3M |
| Begining period cash | -3.06%263.49M | -32.04%271.82M | -32.04%271.82M | 2.30%399.99M | 2.30%399.99M | 9.59%391.01M | 9.59%391.01M | -16.23%356.81M | -16.23%356.81M | 4.35%425.94M |
| Cash at the end | -4.80%240.03M | -3.06%263.49M | -9.47%252.14M | -32.04%271.82M | -28.99%278.51M | 2.30%399.99M | 0.67%392.2M | 9.59%391.01M | 17.52%389.59M | -16.23%356.81M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.